Literature DB >> 27165316

Choose a Suitable Expression Host: A Survey of Available Protein Production Platforms.

Francisco J Fernández1, M Cristina Vega2.   

Abstract

Recombinant overexpression of a protein or a protein complex using any specific heterologous host can be an overwhelming challenge. The reasons may range from low yield and poor solubility of a single-subunit enzyme to the wrong stoichiometry or the incomplete assembly of a multiprotein complex. Whatever the reason, overcoming the difficulties will take the researcher into a journey through the seemingly countless options that exist for protein expression. While some choices stand to reason fairly straightforwardly (e.g., using Escherichia coli for the production of bacterial enzymes), most other choices do not need to be so self-revealing. Here, we attempt to portrait the canvas of available hosts for heterologous expression of many different protein classes and complexes and offer guidance as to which expression host may be more suitable to the problem at hand. The guidance in this chapter must be taken only as a rough indication which will have to be checked against the available literature and corroborated by experiment. It is not only expected but also welcome that, as more knowledge is gathered about the performance of hosts and protein types and new expression systems develop, the information in this chapter will have to be updated and refined.

Entities:  

Keywords:  Baculovirus; E. coli; Expression host; Heterologous expression; Mammalian culture; Protein complex; Yeast

Mesh:

Substances:

Year:  2016        PMID: 27165316     DOI: 10.1007/978-3-319-27216-0_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

1.  Protein Expression Optimization Strategies in E. coli: A Tailored Approach in Strain Selection and Parallelizing Expression Conditions.

Authors:  Shyn Ric Tang; Balaji Somasundaram; Linda H L Lua
Journal:  Methods Mol Biol       Date:  2022

2.  Towards the first multi-epitope recombinant vaccine against Crimean-Congo hemorrhagic fever virus: A computer-aided vaccine design approach.

Authors:  Mokhtar Nosrati; Mandana Behbahani; Hassan Mohabatkar
Journal:  J Biomed Inform       Date:  2019-03-27       Impact factor: 6.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.